| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.17▼ | 2.18▼ | 2.18▼ | 2.19▼ | 2.27▼ |
| MA10 | 2.20▼ | 2.22▼ | 2.22▼ | 2.22▼ | 2.41▼ |
| MA20 | 2.24▼ | 2.28▼ | 2.28▼ | 2.27▼ | 2.25▼ |
| MA50 | 2.35▼ | 2.40▼ | 2.40▼ | 2.38▼ | 2.12▲ |
| MA100 | 2.47▼ | 2.58▼ | 2.48▼ | 2.20▼ | 3.04▼ |
| MA200 | 2.62▼ | 2.60▼ | 2.43▼ | 2.11▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.007▼ | -0.007▼ | -0.003▼ | -0.013▼ |
| RSI | 41.078▼ | 42.079▼ | 42.227▼ | 45.325▼ | 48.417▼ |
| STOCH | 15.581▼ | 25.862 | 25.862 | 46.461 | 25.967 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -69.767 | -86.577▼ |
| CCI | -64.786 | -77.289 | -77.289 | -79.236 | -107.792▼ |
|
Wednesday, February 25, 2026 01:37 AM
Protara Therapeutics (NASDAQ:TARA) shared updated interim data from its ongoing Phase 2, open-label ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle invasive ...
|
|
Tuesday, February 24, 2026 07:23 AM
Protara Therapeutics (NASDAQ:TARA) on February 23, 2026, announced updated interim data from its ongoing Phase 2 ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle ...
|
|
Monday, February 23, 2026 08:56 PM
The interim analysis of the BCG-Unresponsive cohort includes 35 evaluable participants, of whom, 22 were evaluable at six months and 15 were evaluable at 12 months as of a January 28, 2026 data cutoff ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/02/26 | 2.16 | 2.16 | 2.1399 | 2.15 | 3,663 |
| 26/02/26 | 2.285 | 2.285 | 2.21 | 2.21 | 5,200 |
| 25/02/26 | 2.31 | 2.32 | 2.20 | 2.32 | 6,065 |
| 24/02/26 | 2.10 | 2.28 | 2.10 | 2.10 | 7,200 |
| 23/02/26 | 2.2578 | 2.28 | 2.18 | 2.18 | 2,892 |
| 20/02/26 | 2.43 | 2.43 | 2.38 | 2.385 | 2,104 |
| 19/02/26 | 2.2417 | 2.41 | 2.22 | 2.29 | 3,701 |
| 18/02/26 | 2.1908 | 2.28 | 2.1601 | 2.28 | 6,698 |
| 17/02/26 | 2.17 | 2.18 | 2.09 | 2.09 | 5,100 |
| 13/02/26 | 2.02 | 2.23 | 2.02 | 2.17 | 4,800 |
|
|
||||
|
|
||||
|
|